What is Meril?
Founded in 2006, Meril has evolved into a comprehensive MedTech platform headquartered in India, specializing in the design and development of advanced medical technologies. The company maintains a diversified product ecosystem that spans critical therapy areas, including cardiovascular structural heart devices, orthopedic implants, surgical robotics, and in-vitro diagnostics. With a footprint extending across more than 100 countries, Meril distinguishes itself through a vertically integrated model that combines world-class manufacturing capabilities with deep-seated investments in clinical education and training. This strategic approach has allowed the firm to maintain a dominant market position while fostering innovation that addresses unmet clinical needs globally.
How much funding has Meril raised?
Meril has raised a total of $410M across 2 funding rounds:
Private Equity
$210M
Private Equity
$200M
Private Equity (2022): $210M with participation from Warburg Pincus
Private Equity (2025): $200M led by ADIA
Key Investors in Meril
ADIA
Established in 1976, ADIA manages a global investment portfolio that is diversified across several asset classes and sub-categories. The company is headquartered in Abu Dhabi, United Arab Emirates.
Warburg Pincus
Warburg Pincus LLC is a leading global private equity firm renowned for its expertise in growth investing. The firm leverages decades of experience to support management teams in building long-term, sustainable success across diverse market cycles.
What's next for Meril?
With the recent injection of capital, Meril is well-positioned to scale its R&D initiatives and expand its global distribution network. The company is expected to prioritize the advancement of its surgical robotics and cardiovascular portfolios, leveraging its existing manufacturing excellence to meet rising demand in emerging and developed markets. Furthermore, the strategic partnership with its latest investors provides not only financial resources but also the operational expertise necessary to navigate complex regulatory environments and sustain long-term growth. As Meril continues to refine its product pipeline, the focus will likely remain on integrating digital health solutions and enhancing the clinical efficacy of its surgical interventions, ensuring the firm remains at the forefront of the global medical technology landscape.
See full Meril company page
